Baldridge’s award will help fund the use of cutting-edge, high-throughput techniques to study thousands of genetic variants associated with substance use disorders and determine which variants have the greatest molecular consequences. The work ultimately may uncover biological targets for future treatments.
Baldridge receives Avenir Award for early-career scientists (Links to an external site)
